Thanks Gary for not doubting what I was saying and a measured response. I am talking about top tier institution which happens to be very well established for gbm. But his outright dismissal of dcvax perplexed me. Nwbo have destroyed their image and understandably folks are wary of this. However his assertions that neurooncology won’t accept this trial without concurrent control, this product doesn’t work etc. after pressing hard, he did agree that he needs to look at the data from these folks. He happens to know his colleagues at UCLA and hence I was shocked even more with this assertions.
News 
Market Data 
Discover 
AI
